Locations:

Research

December 9, 2019/Cancer/Research

Lenalidomide/Monoclonal Antibody Combination Superior to PI3K Inhibitor Monotherapy as First Novel Agent in Relapsed Follicular Lymphoma

Study assesses outcomes of therapies with novel agents

December 9, 2019/Cancer/Research

Findings Suggest CAR T-Cell Therapy is Highly Effective for Relapsed/Refractory Mantle Cell Lymphoma

Autologous anti-CD19 agent produces impressive survival improvements

December 9, 2019/Cancer/Research

Treatment for Myelofibrosis-Associated Anemia on the Horizon

Interim results of phase 2 trial are promising

September 19, 2019/Cancer/Research

Metabolic Reprogramming: A Promising Approach to Tackling Therapeutic Resistance in Glioblastoma

Targeting pyrimidine synthesis inhibits GSC self-renewal and tumorigenesis

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

September 18, 2019/Cancer/Research

Preoperative Pelvic Radiation is Safe, Effective in Patients with IBD and Rectal Cancer

Study affirms XRT’s utility

September 17, 2019/Cancer/Research

Postprostatectomy Prostate-Specific Antigen Kinetics Associated with Recurrence After Salvage Radiation

Relapse more likely with faster PSA doubling time

August 15, 2019/Cancer/Research

Study Shows Survival Advantage for BEAM Conditioning Regimen in Hodgkin’s Lymphoma

Results prompt clinical practice change

August 14, 2019/Basic & Translational Science

Using Artificial Intelligence to Deliver Personalized Radiation Therapy

Cleveland Clinic-led research employs advanced image analysis to inform dose delivery

June 4, 2019/Cancer/Research

A New Technique for Breast Cancer Lymphatic Mapping: Fluorescent Imaging with Indocyanine Green

Cleveland Clinic study finds it’s safe and effective

June 3, 2019/Cancer/Research

Could Immunotherapy Help Cure Cutaneous Squamous Cell Carcinoma?

Enroll patients now in KEYNOTE-630 trial

BackPage 15 of 24Next